Associated Papers
Advancing Cancer Care in Colombia: Results of the First In Situ Implementation of Comprehensive Genomic Profiling.
López Rivera JJ et al.
Journal of Personalized Medicine, 2024
39338229 (PubMed )
Supplement: jpm-14-00975-s001.zip › SUPPLEMENTARY_DATA.xlsx › Table_S2
TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.
Weich N et al.
Blood Cells, Molecules & Diseases, 2016
The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform.
Cattelani S et al.
Neoplasia (new York, N.y.), 2012
Select a paper to view details